Skip to main content

Abstract

After the discovery of penicillin, systematic programs to search for new antibiotics were initiated. These resulted, in a short time, in the discovery of thousands of active molecules and, most importantly, of a number of clinically useful agents. The basic concepts of these programs, usually termed screening programs, were established by Waksman at Rutgers State University in the early 1940s. They are still valid today and are applied in many academic and industrial research laboratories all over the world.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

General

  • Bérdy, J., 1985, Screening, classification and identification of microbial products, in Discovery and Isolation of Microbial Products ( M. S. Verral, ed.), pp. 9–31, Ellis Horwood, Chichester.

    Google Scholar 

  • Bérdy, J., Aszalos, A., Bostian, M., and McNitt, K. L., 1980–1982, Handbook ofAntibiotic Compounds,Vols. I-X, CRC Press, Boca Raton, Fla.

    Google Scholar 

  • Betina, V., 1983, The Chemistry and Biology of Antibiotics, pp. 59–101, Elsevier, Amsterdam.

    Google Scholar 

  • Box, S. J., 1985, Approaches to the isolation of an unidentified microbial product, in Discovery and Isolation of Microbial Products ( M. S. Verrai, ed.), pp. 32–51, Ellis Horwood, Chichester.

    Google Scholar 

  • Bu’Lock, J. D., Nisbet, L. J., and Winstanley, D. J., (eds.), 1982, Bioactive Microbial Products: Search and Discovery, Academic Press, New York.

    Google Scholar 

  • Elander, R. P., 1987, Microbial screening, selection and strain improvement, in Basic Biotechnology ( J. Bu’Lock and B. Kristiansen, eds.), pp. 217–251, Academic Press, New York.

    Google Scholar 

  • Gootz, J. D., 1990, Discovery and development of new antimicrobial agents, Clin. Microbiol. Rev. 3: 13.

    PubMed  CAS  Google Scholar 

  • Imada, A., and Hotta, K., 1992, Hystorical perspectives of approaches to antibiotics discovery, in Emerging Targets in Antibacterial and Antifungal Chemotherapy ( J. A. Sutcliffe and N. H. Georgopapadaku, eds.), pp. 1–23, Chapman and Hall, London.

    Chapter  Google Scholar 

  • Iwai, Y., and Ömura, S., 1982, Culture conditions for screening of new antibiotics, J. Antibiot. 35: 123.

    Article  PubMed  CAS  Google Scholar 

Strain Isolation

  • Cross, T., 1982, Actinomycetes: A continuing source of new metabolites, Dey. Ind. Microbiol. 23: 1.

    Google Scholar 

  • Dreyfuss, M. M., 1992, Ecology, microbial diversity and chemical creativity, in New Drugs from Natural Sources ( J. D. Coombs, ed.), pp. 59–62, IBC Technical Services, London.

    Google Scholar 

  • Frankland, J. C., Dighton, J., and Boddy, L., 1990, Methods for studying fungi in soil and forest litter, Methods Microbiol. 22: 343.

    Article  Google Scholar 

  • Hunter-Cevera, J. C., Fonda, M. E., and Belt, A., 1986, Isolation of cultures, in Manual of Industrial Microbiology and Biotechnology ( A. L. Demain and N. A. Solomon, eds.), pp. 3–23, American Society for Microbiology, Washington, D.C.

    Google Scholar 

  • Li, G. P., 1989, Isolation of actinomycetes for antibiotic screening, Chin. J. Antibiot. 14: 452.

    Google Scholar 

  • Nisbet, L. J., 1992, Natural solutions for the drug industry. An overview, in New Drugs from Natural Sources ( D. Coombes, ed.), pp. 185–190, IBC Technical Services, London.

    Google Scholar 

  • Nolan, R. D., and Cross, T., 1988, Isolation and screening of actinomycetes, in Actinomycetes in Biotechnology ( M. Goodfellow, S. T. Williams, and M. Mordarski, eds.), pp. 1–32, Academic Press, New York.

    Chapter  Google Scholar 

  • O’Donnell, K., and Peterson, S. W., 1992, Isolation, preservation and taxonomy, in Biotechnology of Filamentous Fungi ( D. B. Finkelstein and C. Ball, eds.), pp. 739, Butterworths/Heinemann, London.

    Google Scholar 

  • Reichenbach, M., and Höfle, G., 1989, The gliding bacteria: A treasury of secondary metabolites, Prog. Ind. Microbiol. 27: 79.

    Google Scholar 

  • Wellington, E. M. H., and Cross, T., 1983, Taxonomy of antibiotic producing actinomycetes and new approaches for their selective isolation, Prog. Ind. Microbiol. 17: 1983.

    Google Scholar 

  • Wells, J. S., Hunter, J. C., Astle, G. L., Sherwood, J. C., Ricca, C. M., Trejo, W. H., Bonner, D. P., and Sykes, R. B., 1982, Distribution of ß-lactam and ß-lactone producing bacteria in nature, J. Antibiot. 35: 814.

    Article  PubMed  CAS  Google Scholar 

Innovative Assays

  • Bérdy, J., 1989, The discovery of new bioactive microbial metabolites: Screening and identification, Prog. Ind. Microbiol. 27: 3.

    Google Scholar 

  • Gadebush, H. H., Stapley, E. O., and Zimmerman, S. B., 1992, The discovery of cell wall active antibacterial antibiotics, Crit. Rev. Biotechnol. 12: 225.

    Article  Google Scholar 

  • Harris, T. J. R., Hayes, M. V., and Hobden, A. N., 1992, Molecular genetics in natural product screen design, in New Drugs from Natural Sources ( J. D. Coombes, ed.), pp. 3–12, IBC Technical Services, London.

    Google Scholar 

  • Hertzberg, R. P., Johnson, R. K., Caranfa, M. J., Myers, C. C., Mackenzie, L., Breen, A., Tomaszek, T. A., Meek, T. D., Debouck, C., Mai, S. H., Culp, J. S., and Francis, T. A., 1992, Mechanism based strategies for the discovery of natural product in-hibitors of HIV, in New Drugs from Natural Sources ( J. D. Coombes, ed.), pp. 4658, IBC Technical Services, London.

    Google Scholar 

  • Monaghan, R. L., and Tkacz, J. S., 1990, Bioactive microbial products: Focus upon mechanism of action, Annu. Rev. Microbiol. 44: 271.

    Article  PubMed  CAS  Google Scholar 

  • Nisbet, L. J., and Westley, J. W., 1986, Developments in microbial products screening, Annu. Rep. Med. Chem. 21: 148.

    Google Scholar 

  • Ömura, S., 1986, Philosophy of new drug discovery, Microbiol. Rev. 50: 259.

    PubMed  Google Scholar 

  • Ryley, J. F., and Barret-Bee, K., 1992, Screening for antifungal activity, in Emerging Targets in Antibacterial and Antifungal Chemotherapy ( J. A. Sutcliffe and N. H. Georgopapadaku, eds.), pp. 546–567, Chapman and Hall, London.

    Chapter  Google Scholar 

  • Schindler, P. W., 1992, The design and operation of enzyme inhibitor screens, in New Drugs from Natural Sources ( J. D. Coombes, ed.), pp. 20–35, IBC Technical Services, London.

    Google Scholar 

  • Selitrennikoff, C. P., 1992, Screening for antifungal drugs, in Biotechnology of Filamentous Fungi ( D. B. Finkelstein and C. Ball, eds.), pp. 189–217, Butterworths/Heinemann, London.

    Google Scholar 

  • White, R. J., and Maiese, W. M., 1983, Detection of microbial metabolites with antitumor activity, Frog. Ind. Microbiol. 17: 167.

    CAS  Google Scholar 

  • White, R. J., Maiese, W. M., and Greenstein, M., 1986, Screening of new products from microorganisms, in Manual of Industrial Microbiology and Biotechnology ( A. L. Demain and N. A. Solomon, eds.), pp. 24–31, American Society for Microbiology, Washington D.C.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer Science+Business Media New York

About this chapter

Cite this chapter

Lancini, G., Lorenzetti, R. (1993). The Search for New Bioactive Microbial Metabolites. In: Biotechnology of Antibiotics and Other Bioactive Microbial Metabolites. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9522-6_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-9522-6_3

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-9524-0

  • Online ISBN: 978-1-4757-9522-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics